Together in care, research, and education

Focus on care and research with societal impact

Our care and part of our research is increasingly shifting to high complexity care for patients with rare diseases from our regional and supra regional collaborations. Not only are we broadening our knowledge and expertise in the treatment of the primary complications of high complexity care, our role goes further: we can contribute to the provision of good, accessible and appropriate care for patients with more common disorders. Over the coming years, we choose in favour of patient care and research, with a focus on regenerative medicine, population health, data driven healthcare & AI with the overarching aim of tackling the major issues facing society

Mutual connection between our academic healthcare profile and our research themes

To refocus our choices, we need a clear criterion, the criterion we have chosen is the mutual connection between our academic healthcare profile and our research themes. At the same time, we must still hold space for our fundamental research. Our current ten research teams will remain in place while we await the results of the external research visit in the autumn of 2024.

Any additional further focus will require the integration of care with existing research themes, wherever possible. Research groups which are less heavily involved in the academic care pathways, will be encouraged to establish more contacts with clinical care. This will help reinforce the awareness among our researchers into the clinical care portfolio and its related challenges. It will also encourage the researchers, in their academic role, to seek closer ties with specifi c questions coming from patient care. And Additionally, it works in both directions: clinical research is strengthened through intensive contact with the more fundamental research groups. We achieve this interaction, among others, by linking specific clinicians involved in the academic healthcare pathways to the leaders of fundamental research groups.